Sub Heading

Clinical Trials Details

Master Protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (Lung-MAP Screening Study)

IRB Protocol Number
LUNGMAP

Clinical Trial Categories

  • Lung Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, DISEASE MUST BE EITHER ADVANCED, stage IIIB or IV or recurrent.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.